Skip to main content

An ASM-CLSI Webinar Series on Antimicrobial Susceptibility Testing: Advanced Susceptibility Testing and Emerging Technologies (No CEs Available)

Supported in part by Accelerate Diagnostics.
This webinar series on Antimicrobial Susceptibility Testing (AST) in the clinical microbiology laboratory focuses on cases regarding situations in which specialized susceptibility testing for organisms other than common, rapidly-growing aerobic bacteria should be performed. Topics include AST for fastidious bacteria, anaerobic bacteria, yeasts, filamentous fungi, and nontuberculosis mycobacteria. This course provides a foundation on antifungal and anti-mycobacterial drug classes, their modes of action, spectrum of activity, pharmacokinetics/pharmacodynamics (PK/PD), and common mechanisms of resistance. This series is part three of the ASM-CLSI AST series.

Part 1 and Part 2 of this AST webinar series are currently available on demand on ASM Events Online.

Level of Instruction: Advanced

Target Audience: Laboratory Technologists.

Format: This is a series with four, one-hour webinars. The webinars are previously recorded presentations. Each webinar will include a 50-minute presentation and a 10-minute Q&A.

The webinars' content does not build on the previous webinars in the series. All of the content is independent so learners can purchase only those that meet their needs.

This webinar is sold to individuals and not to institutions; therefore the purchaser’s webinar login access should not be share with others.

For individuals- The series is composed of five topics and they can be purchased singularly or as a bundle.
ASM Clinical Laboratory Scientist Members ASM Premium & Contributing Members ASM Supporting Members & Non-Members
Single Webinar $5 $10 $15
Bundle (All Five Webinars) $25 $40 $60

Visit to become an ASM member.

Continuing Education (CE) Credit:
This series is not available for CE credit.

Please email ASM if you require closed captioning.

Series Topics: 
  • Susceptibility Testing for Fastidious Bacteria, Including Anaerobes
  • Susceptibility Testing for Yeasts and Filamentous Fungi
  • Susceptibility Testing for Slowly- and Rapidly- Growing Nontuberculous
  • Answering Today’s Most Commonly Encountered AST Questions: A Case Based Approach

Supplemental Materials:
Missed Accelerate Diagnostics' cutting-edge presentations at ASM Microbe 2018? Here's your chance to view them for free!

Antibiotic Susceptibility Testing Direct from Positive Blood Cultures: Challenges and Opportunities for Pediatric and Immunocompromised Patients with Bacteremia

Antibiotic Susceptibility Testing Direct from Positive Blood Cultures: Challenges and Opportunities in the Academic Medical Center Setting
Providing phenotypic antimicrobial susceptibility results to clinicians can significantly affect patient outcomes and is, arguably, one of the most important activities performed by clinical microbiology laboratories. This symposium focused on direct from positive blood culture phenotypic antibiotic susceptibility testing and the challenges and opportunities in integrating this new technology into antimicrobial stewardship programs. Additionally, presenters discussed the impact of early susceptibility results on the management patients with Gram-negative bacteremia.

If you are purchasing all four topics click this “Add to Cart” to get the bundle price. Adding all topics to your cart individually will result in a higher fee.

blog comments powered by Disqus